Skip to content
TrialScanner

NCT06391177

A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily

Phase 1CompletedPHATLead

Registry record

Lead sponsor
Phathom Pharmaceuticals, Inc.
Conditions
Erosive Esophagitis; Heartburn; Symptomatic Nonerosive Gasroesophageal Reflux Disease; Helicobacter Pylori Infection
Primary completion
Sep 13, 2024Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06391177 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT06391177: A Study to Evaluate Vonopraza... | TrialScanner